Yeji
NDA/BLA filedconf 0.95

zidesamtinib — NDA/BLA filed

$NUVL · Nuvalent, Inc. · tyrosine kinase inhibitor pre-treated patients with advanced ROS1-positive non-small cell lung cancer
Event date
September 22, 2025
257 days ago
Sponsor runway
42 mo
$1.29B liquid

Evidence

On September 22, 2025, Nuvalent, Inc. announced the completion of its New Drug Application submission to the U.S. Food and Drug Administration for zidesamtinib in tyrosine kinase inhibitor pre-treated patients with advanced ROS1-positive non-small cell lung cancer.
Source: 8-K filed 2025-09-22View on EDGAR ↗0001193125-25-209934

Comparable historical nda/bla fileds· last 5 years · same event type

TickerDrugDateOutcome
$AXSM2025-12-31unknown
$RCKTkresladi2025-10-14unknown
$ALDXreproxalap2025-07-17unknown
$ETONet-6002025-07-08unknown
$BCRXorladeyo (berotralstat)2025-05-14unknown
$CORTrelacorilant2025-03-03unknown
$ALDXreproxalap2024-11-01unknown
$AXSMaxs-072024-09-04unknown
$RCKTkresladi2023-10-02unknown
$GERNimetelstat2023-08-21unknown

Recent insider activity· ±90 days

8 insiders · 0 buys · 104 sells
Grant
2025-12-10
Squarer Ron
Director
2,837 @
Grant
2025-12-10
Squarer Ron
Director
4,418 @
Sell10b5-1
2025-12-08
Balcom Alexandra
Chief Financial Officer
100 @ $111.32$11K
Sell10b5-1
2025-12-08
Balcom Alexandra
Chief Financial Officer
6,984 @ $110.31$770K
Exercise10b5-1
2025-11-28
Noci Darlene
Chief Development Officer
4,000 @ $27.85$111K
Sell10b5-1
2025-11-28
Noci Darlene
Chief Development Officer
645 @ $107.85$70K
Sell10b5-1
2025-11-28
Noci Darlene
Chief Development Officer
3,355 @ $108.72$365K
Sell10b5-1
2025-11-24
Shair Matthew
Director
2,026 @ $109.77$222K
Sell10b5-1
2025-11-24
Shair Matthew
Director
1,193 @ $110.42$132K
Sell10b5-1
2025-11-24
Shair Matthew
Director
336 @ $110.42$37K
Sell10b5-1
2025-11-24
Shair Matthew
Director
2,262 @ $108.73$246K
Sell10b5-1
2025-11-24
Shair Matthew
Director
638 @ $108.73$69K
Sell10b5-1
2025-11-24
Shair Matthew
Director
572 @ $109.77$63K
Sell
2025-11-24
Flynn James E
Director
371,287 @ $95.44$35.44M
Sell10b5-1
2025-11-24
Shair Matthew
Director
369 @ $107.70$40K
Sell10b5-1
2025-11-24
Shair Matthew
Director
104 @ $107.70$11K
Sell10b5-1
2025-11-18
Balcom Alexandra
Chief Financial Officer
509 @ $104.54$53K
Sell10b5-1
2025-11-18
Balcom Alexandra
Chief Financial Officer
220 @ $103.61$23K
Exercise10b5-1
2025-11-18
Balcom Alexandra
Chief Financial Officer
729 @ $72.35$53K
Sell10b5-1
2025-11-17
Miller Deborah Ann
Chief Legal Officer
608 @ $107.04$65K
Exercise10b5-1
2025-11-17
Balcom Alexandra
Chief Financial Officer
13,125 @ $72.35$950K
Sell10b5-1
2025-11-17
Balcom Alexandra
Chief Financial Officer
3,609 @ $93.80$339K
Sell10b5-1
2025-11-17
Balcom Alexandra
Chief Financial Officer
3,266 @ $95.12$311K
Sell10b5-1
2025-11-17
Balcom Alexandra
Chief Financial Officer
4,496 @ $100.58$452K
Sell10b5-1
2025-11-17
Balcom Alexandra
Chief Financial Officer
3,194 @ $102.13$326K
Sell10b5-1
2025-11-17
Balcom Alexandra
Chief Financial Officer
5,055 @ $103.27$522K
Sell10b5-1
2025-11-17
Balcom Alexandra
Chief Financial Officer
380 @ $103.68$39K
Exercise10b5-1
2025-11-17
Miller Deborah Ann
Chief Legal Officer
24,200 @ $6.89$167K
Sell10b5-1
2025-11-17
Miller Deborah Ann
Chief Legal Officer
15,075 @ $105.16$1.59M
Sell10b5-1
2025-11-17
Miller Deborah Ann
Chief Legal Officer
8,517 @ $105.98$903K
Exercise10b5-1
2025-11-17
Balcom Alexandra
Chief Financial Officer
6,875 @ $6.89$47K
Sell10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
2,121 @ $102.00$216K
Exercise10b5-1
2025-10-30
Noci Darlene
Chief Development Officer
4,000 @ $27.85$111K
Sell10b5-1
2025-10-30
Noci Darlene
Chief Development Officer
57 @ $98.91$6K
Sell10b5-1
2025-10-30
Noci Darlene
Chief Development Officer
350 @ $100.69$35K
Sell10b5-1
2025-10-30
Noci Darlene
Chief Development Officer
1,170 @ $102.07$119K
Sell10b5-1
2025-10-30
Noci Darlene
Chief Development Officer
1,091 @ $103.09$112K
Sell10b5-1
2025-10-30
Noci Darlene
Chief Development Officer
1,114 @ $104.21$116K
Sell10b5-1
2025-10-30
Noci Darlene
Chief Development Officer
218 @ $104.58$23K
Exercise10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
21,800 @ $6.89$150K
Sell10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
700 @ $96.65$68K
Sell10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
1,273 @ $97.98$125K
Sell10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
500 @ $99.66$50K
Sell10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
600 @ $100.96$61K
Sell10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
3,733 @ $102.88$384K
Sell10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
3,491 @ $103.90$363K
Sell10b5-1
2025-10-30
Miller Deborah Ann
Chief Legal Officer
9,382 @ $104.78$983K
Sell10b5-1
2025-10-28
Shair Matthew
Director
9,154 @ $100.27$918K
Sell10b5-1
2025-10-28
Shair Matthew
Director
32,455 @ $100.27$3.25M
Sell10b5-1
2025-10-27
Shair Matthew
Director
4,046 @ $100.23$406K
+ 109 more